
    
      Women > 38 years, who had an insufficient response to stimulation with regular (for age)
      posology of 225 IU of gonadotrophins (urinary or recombinant), in an agonist protocol will be
      randomized prospectively into 2 groups:

      300 IU versus 450 IU of Gonal-f® administered in a short agonist protocol. Insufficient
      response is defined as: development of ≤ 4 mature follicles (of ≥ 16 mm) at time of hCG
      administration.

      Patient can be eligible for several cycles in same protocol.
    
  